MariHealth Solutions

About MariHealth Solutions

MariHealth Solutions is an aquaculture proteomics company based in Cape Town, South Africa. Founded in 2021 as a spinout from the University of Cape Town, it helps aquaculture businesses, researchers, and health specialists understand what is happening inside fish at the molecular level, using protein-based analysis rather than relying only on traditional diagnostics.

The company positions itself as purpose-built for aquaculture, with a workflow designed around fish health, nutrition, welfare, and farming practices. Its services are aimed at customers who need deeper biological evidence for R&D, ingredient validation, vaccine assessment, stress and welfare monitoring, and other questions where growth metrics or routine tests do not tell the full story.

Core Values

• Scientific rigour: The company emphasises structured workflows, quality control, documented methodology, and honest interpretation. It states that if the data do not support a clear conclusion, it will say so.
• Aquaculture relevance: MariHealth builds its pipeline around aquaculture biology rather than adapting human or biomedical workflows. Its interpretation is grounded in fish health, nutrition, welfare, and field reality.
• Partnership and support: The service is designed as an end-to-end collaboration, from study design through to results walkthrough. The company presents itself as a partner that helps clients understand both the data and what to do next.
• Innovation with practical impact: MariHealth focuses on turning molecular insight into better decisions for R&D, ingredient validation, and farm management. Its broader vision includes future diagnostics and therapeutics built from proteomics discoveries.

Unique Aspects

• Purpose-built for aquaculture proteomics: MariHealth says it is the only proteomics company purpose-built for aquaculture, with a pipeline and interpretation model tailored to fish biology rather than general life-science use.
• University spinout origins: The company was founded in 2021 as a spinout from the University of Cape Town, and its early development was backed by the University Technology Fund.
• Advanced analytical platform: It uses LC-MS/MS with a diaPASEF workflow on the Bruker timsTOF platform, through a partnership with the Centre for Proteomic and Genomic Research in Cape Town.
• No cold-chain shipping: Its sample preparation approach allows ambient-temperature shipping, which reduces logistical complexity for aquaculture projects across different regions.
• Growing proprietary database: Every project contributes to a species- and context-specific aquaculture protein database, which the company says improves analytical depth over time.
• International expansion and traction: The company notes a growing presence in Europe, including a Netherlands entity, and says it has served clients across three continents.